184 related articles for article (PubMed ID: 18045073)
1. Recent approaches in chemoprevention of prostate cancer.
Young CY
Curr Cancer Drug Targets; 2007 Nov; 7(7):681-8. PubMed ID: 18045073
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of prostate cancer.
Kucuk O
Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
[TBL] [Abstract][Full Text] [Related]
3. Carotenoids and prostate cancer risk.
Young CY; Yuan HQ; He ML; Zhang JY
Mini Rev Med Chem; 2008 May; 8(5):529-37. PubMed ID: 18473940
[TBL] [Abstract][Full Text] [Related]
4. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
Fujimoto N; Chang C; Nomura M; Matsumoto T
Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications.
Chhabra G; Singh CK; Ndiaye MA; Fedorowicz S; Molot A; Ahmad N
Cancer Lett; 2018 May; 422():9-18. PubMed ID: 29471004
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer: current status and future directions.
Lieberman R
Cancer Metastasis Rev; 2002; 21(3-4):297-309. PubMed ID: 12549768
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
Lieberman R
Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer prevention: agent development strategies.
Parnes HL; House MG; Tangrea JA
Recent Results Cancer Res; 2014; 202():121-31. PubMed ID: 24531786
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of prostate cancer.
Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
[TBL] [Abstract][Full Text] [Related]
10. [Chemoprevention of prostate cancer].
Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
[TBL] [Abstract][Full Text] [Related]
11. [Chemoprevention of prostate cancer].
Xie LP; Qin J
Zhonghua Nan Ke Xue; 2005 Apr; 11(4):243-6. PubMed ID: 15921250
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention in prostate cancer.
Assikis V; Brawley OW
Curr Probl Cancer; 2004; 28(4):218-30. PubMed ID: 15318324
[No Abstract] [Full Text] [Related]
13. Advances in prostate cancer chemoprevention: a translational perspective.
Nambiar D; Singh RP
Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of prostate cancer.
Rittmaster RS
Acta Oncol; 2011 Jun; 50 Suppl 1():127-36. PubMed ID: 21604953
[TBL] [Abstract][Full Text] [Related]
15. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants for prostate cancer chemoprevention: challenges and opportunities.
Thapa D; Ghosh R
Biochem Pharmacol; 2012 May; 83(10):1319-30. PubMed ID: 22248733
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of novel agents for prostate cancer chemoprevention.
Singh RP; Agarwal R
Endocr Relat Cancer; 2006 Sep; 13(3):751-78. PubMed ID: 16954429
[TBL] [Abstract][Full Text] [Related]
19. Target populations and strategies for chemoprevention trials of prostate cancer.
Bostwick DG
J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
[TBL] [Abstract][Full Text] [Related]
20. Natural Compounds in Prostate Cancer Prevention and Treatment: Mechanisms of Action and Molecular Targets.
Fontana F; Raimondi M; Marzagalli M; Di Domizio A; Limonta P
Cells; 2020 Feb; 9(2):. PubMed ID: 32085497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
